Compare GSK Consumer with TILAKNAGAR IND. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs TILAKNAGAR IND. - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER TILAKNAGAR IND. GSK CONSUMER/
TILAKNAGAR IND.
 
P/E (TTM) x 39.1 -1.5 - View Chart
P/BV x 11.0 - - View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 GSK CONSUMER   TILAKNAGAR IND.
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
TILAKNAGAR IND.
Mar-19
GSK CONSUMER/
TILAKNAGAR IND.
5-Yr Chart
Click to enlarge
High Rs7,81924 32,717.2%   
Low Rs5,83213 43,847.4%   
Sales per share (Unadj.) Rs1,136.952.7 2,157.4%  
Earnings per share (Unadj.) Rs233.7-12.7 -1,833.0%  
Cash flow per share (Unadj.) Rs248.1-9.8 -2,528.5%  
Dividends per share (Unadj.) Rs105.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs973.5-23.0 -4,241.3%  
Shares outstanding (eoy) m42.06125.13 33.6%   
Bonus/Rights/Conversions -B-  
Price / Sales ratio x6.00.4 1,700.9%   
Avg P/E ratio x29.2-1.5 -2,002.0%  
P/CF ratio (eoy) x27.5-1.9 -1,451.3%  
Price / Book Value ratio x7.0-0.8 -865.2%  
Dividend payout %44.90-   
Avg Mkt Cap Rs m287,0832,327 12,334.8%   
No. of employees `0003.80.3 1,353.5%   
Total wages/salary Rs m6,446333 1,937.0%   
Avg. sales/employee Rs Th12,440.223,219.2 53.6%   
Avg. wages/employee Rs Th1,677.01,171.8 143.1%   
Avg. net profit/employee Rs Th2,556.7-5,616.5 -45.5%   
INCOME DATA
Net Sales Rs m47,8206,594 725.2%  
Other income Rs m4,32652 8,303.3%   
Total revenues Rs m52,1466,646 784.6%   
Gross profit Rs m11,410561 2,032.5%  
Depreciation Rs m606368 164.8%   
Interest Rs m81,842 0.4%   
Profit before tax Rs m15,123-1,596 -947.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,295-1 -529,490.0%   
Profit after tax Rs m9,828-1,595 -616.1%  
Gross profit margin %23.98.5 280.3%  
Effective tax rate %35.00.1 55,883.4%   
Net profit margin %20.6-24.2 -85.0%  
BALANCE SHEET DATA
Current assets Rs m52,6744,822 1,092.4%   
Current liabilities Rs m18,14014,227 127.5%   
Net working cap to sales %72.2-142.6 -50.6%  
Current ratio x2.90.3 856.8%  
Inventory Days Days3654 65.6%  
Debtors Days Days29133 22.1%  
Net fixed assets Rs m4,7986,659 72.1%   
Share capital Rs m4211,251 33.6%   
"Free" reserves Rs m40,527-4,124 -982.8%   
Net worth Rs m40,947-2,872 -1,425.6%   
Long term debt Rs m01 0.0%   
Total assets Rs m60,68112,811 473.7%  
Interest coverage x1,939.80.1 1,452,588.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.5 153.1%   
Return on assets %16.21.9 840.7%  
Return on equity %24.055.5 43.2%  
Return on capital %37.0-8.6 -431.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,17119 16,706.5%   
Fx outflow Rs m1,7702 80,824.2%   
Net fx Rs m1,40117 8,343.3%   
CASH FLOW
From Operations Rs m6,711908 739.3%  
From Investments Rs m-3,351-31 10,704.8%  
From Financial Activity Rs m-3,768-1,043 361.2%  
Net Cashflow Rs m-408-167 244.6%  

Share Holding

Indian Promoters % 0.0 55.0 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 0.2 470.6%  
FIIs % 12.0 0.9 1,333.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 43.9 33.7%  
Shareholders   26,457 37,604 70.4%  
Pledged promoter(s) holding % 0.0 85.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   NESTLE  SAVITA OIL  MCLEOD RUSSEL  KAVERI SEED  ZYDUS WELLNESS  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  NESTLE (Switz.)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Ends Marginally Higher; Realty and Telecom Stocks Witness Buying(Closing)

Indian share markets erased gains during the last hour of trading in today's volatile session, but still ended marginally higher.

Related Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

TILAKNAGAR IND. Announces Quarterly Results (1QFY20); Net Profit Up 5.7% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TILAKNAGAR IND. has posted a net profit of Rs 370 m (up 5.7% YoY). Sales on the other hand came in at Rs 3 bn (down 1.1% YoY). Read on for a complete analysis of TILAKNAGAR IND.'s quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY19); Net Profit Up 34.9% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 34.9% YoY). Sales on the other hand came in at Rs 13 bn (up 9.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC(Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

How to Shortlist the Best Stocks for Trading(Fast Profits Daily)

Oct 7, 2020

In this video, I'll show you how to identify a confluence of factors in the market which will point you to the best stocks to trade.

The Inflection Point for Defence Stocks is Getting Closer(Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS